Coordinate Regulation of Estrogen-Mediated Fibronectin Matrix Assembly and Epidermal Growth Factor Receptor Transactivation by the G Protein-Coupled Receptor, GPR30
Open Access
- 1 July 2009
- journal article
- other
- Published by The Endocrine Society in Molecular Endocrinology
- Vol. 23 (7), 1052-1064
- https://doi.org/10.1210/me.2008-0262
Abstract
Estrogen promotes changes in cytoskeletal architecture not easily attributed to the biological action of estrogen receptors, ERα and ERβ. The Gs protein-coupled transmembrane receptor, GPR30, is linked to specific estrogen binding and rapid estrogen-mediated release of heparin-bound epidermal growth factor. Using marker rescue and dominant interfering mutant strategies, we show that estrogen action via GPR30 promotes fibronectin (FN) matrix assembly by human breast cancer cells. Stimulation with 17β-estradiol or the ER antagonist, ICI 182, 780, results in the recruitment of FN-engaged integrin α5β1 conformers to fibrillar adhesions and the synthesis of FN fibrils. Concurrent with this cellular response, GPR30 promotes the formation of Src-dependent, Shc-integrin α5β1 complexes. Function-blocking antibodies directed against integrin α5β1 or soluble Arg-Gly-Asp peptide fragments derived from FN specifically inhibited GPR30-mediated epidermal growth factor receptor transactivation. Estrogen-mediated FN matrix assembly and epidermal growth factor receptor transactivation were similarly disrupted in integrin β1-deficient GE11 cells, whereas reintroduction of integrin β1 into GE11 cells restored these responses. Mutant Shc (317Y/F) blocked GPR30-induced FN matrix assembly and tyrosyl phosphorylation of erbB1. Interestingly, relative to recombinant wild-type Shc, 317Y/F Shc was more readily retained in GPR30-induced integrin α5β1 complexes, yet this mutant did not prevent endogenous Shc-integrin α5β1 complex formation. Our results suggest that GPR30 coordinates estrogen-mediated FN matrix assembly and growth factor release in human breast cancer cells via a Shc-dependent signaling mechanism that activates integrin α5β1.Keywords
This publication has 66 references indexed in Scilit:
- Fibronectin Expression Modulates Mammary Epithelial Cell Proliferation during Acinar DifferentiationCancer Research, 2008
- Rapid expression and activation of MMP-2 and MMP-9 upon exposure of human breast cancer cells (MCF-7) to fibronectin in serum free mediumLife Sciences, 2007
- Akt1 Signaling Regulates Integrin Activation, Matrix Recognition, and Fibronectin AssemblyJournal of Biological Chemistry, 2007
- Structural Basis of Integrin Regulation and SignalingAnnual Review of Immunology, 2007
- Crystal structures of VAP1 reveal ADAMs' MDC domain architecture and its unique C-shaped scaffoldThe EMBO Journal, 2006
- Stimulatory effects of a three-dimensional microenvironment on cell-mediated fibronectin fibrillogenesisJournal of Cell Science, 2005
- A Novel Mode for Integrin-mediated Signaling: Tethering Is Required for Phosphorylation of FAK Y397Molecular Biology of the Cell, 2003
- Binding of a5 Monoclonal Antibody to Cell Surface a5b1 Integrin Modulates MMP-2 and MMP-7 Activity in B16F10 MeJournal of Environmental Pathology, Toxicology and Oncology, 2003
- Bombesin-Dependent Pro-MMP-9 Activation in Prostatic Cancer Cells Requires β1 Integrin EngagementExperimental Cell Research, 2002
- Regulatory Role for Src and Phosphatidylinositol 3-Kinase in Initiation of Fibronectin Matrix AssemblyPublished by Elsevier BV ,2002